Richard N Channick

8PUBLICATIONS
64CO-AUTHORS
Respiratory diseasesClinical pharmacology and therapeuticsMajor global burdens of diseaseCardiovascular medicine and haematology not elsewhere classifiedEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 03, 2025
Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial.

Robert A Lookstein, Stavros V Konstantinides, Ido Weinberg

|Aug 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.

Olivier Sitbon, Sandeep Sahay, Pilar Escribano Subías

|Aug 29, 2024
Pulmonary hypertension associated with lung diseases.

Oksana A Shlobin, Yochai Adir, Joan A Barbera

|Mar 07, 2024
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.

Richard Channick, Kelly M Chin, Vallerie V McLaughlin

|Feb 13, 2024
Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system.

Katharina Mohr, Brent Keeling, Klaus Kaier

|Apr 13, 2021
The United States Chronic Thromboembolic Pulmonary Hypertension Registry: Protocol for a Prospective, Longitudinal Study.

Kim M Kerr, C Greg Elliott, Raymond L Benza

Pageof 2

Frequent Collaborators

3 joint publications

Hossein-Ardeschir Ghofrani

3 joint publications

Vallerie V McLaughlin

3 joint publications

Kelly M Chin

3 joint publications

Raymond L Benza